Journal
ENZYME AND MICROBIAL TECHNOLOGY
Volume 104, Issue -, Pages 56-68Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.enzmictec.2017.05.010
Keywords
Antibiotic-susceptibility test; Carbapenem; Laser desorption/ionization mass spectrometry (LDI MS); MALDI-TOF MS; Parylene-matrix chip
Categories
Funding
- Nano-Convergence Foundation - Ministry of Science, ICT and Future Planning (MSIP, Korea) [R201602210]
- Industry Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Korea), [10063335]
- National Research Foundation of Korea [NRF-2017R1A2B4004077, NRF-2017R1A2B2004398]
- National Research Foundation of Korea [R201602210] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
A quantitative carbapenemase assay was developed using laser desorption/ionization mass spectrometry (LDI-MS) based on a parylene-matrix chip. As a first step, the reproducibility (spot-to-spot, shot-to-shot,and day-to-day) of LDI-MS based on a parylene-matrix chip and the quantification ranges for four carbapenem antibiotics (doripenem, ertapenem, imipenem, and meropenem) were determined. A carbapenem-susceptibility test was performed using the four carbapenems and 51 bacterial strains that displayed (1) carbapenem resistance with carbapenemase, (2) carbapenem resistance without carbapenemase, or (3) carbapenem susceptibility. The susceptibility test results showed that LDI-MS based on a parylene-matrix chip was more sensitive and selective for detecting the carbapenemase reaction than conventional MALDI-TOF MS based on a 2,5-dihydroxybenzoic acid matrix.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available